Debates
Cholesterol and heart disease
Does replacing dietary saturated fat with polyunsaturated fats reduce cardiovascular disease or mortality risk in humans?
The dispute is whether replacing dietary saturated fat with polyunsaturated fats lowers cardiovascular disease or death risk in humans.
Does lowering LDL-related lipoproteins (LDL-C or ApoB/LDL-P) meaningfully reduce cardiovascular disease and related outcomes risk for most people?
The shows debate whether lowering LDL-related particles substantially cuts cardiovascular events or has only minimal impact on heart disease and stroke risk.
Does regularly eating a diet high in saturated fat and cholesterol increase cardiovascular disease risk for most people?
Podcasts argue over whether regularly eating lots of saturated fat and cholesterol raises cardiovascular disease risk for most people.
Do statin medications, as currently prescribed, provide substantial net health benefits and prevent many premature deaths?
The dispute is whether statin medications provide large net health benefits or instead offer little benefit while causing major harm.
Do statins meaningfully reduce the risk of heart attack, stroke, or cardiovascular death?
Speakers dispute whether statins meaningfully reduce cardiovascular event risk.
Seed oils and saturated fats
Does industrial processing of seed oils make them unhealthy to consume?
From October through July, speakers have disputed whether industrial processing of seed oils makes them unhealthy to consume.
Are seed oils uniquely harmful to human health compared with other dietary fats?
The dispute is whether seed oils are uniquely harmful to human health compared with other dietary fats.
Do seed oils oxidize readily under typical storage and cooking conditions?
From late 2025 into 2026, guests have disputed whether seed oils oxidize under typical storage and cooking.
Fasting and longevity
Does deliberately reducing mTOR activity through drugs or diet improve human healthspan or longevity?
The dispute is whether deliberately lowering mTOR with drugs or diet slows human aging or instead harms healthspan and lifespan.
Government regulation and capture
Do government interventions in markets generally do more harm than good and therefore should be minimized?
This debate appears in podcast conversations from January through mid October, asking whether government market interventions do more harm than good overall.
Diet and obesity causes
Should most adults deliberately eat a high-fiber diet to improve gut microbiome function and overall health?
Podcasts debate whether most adults should deliberately eat high‑fiber diets for gut microbes and health, avoid more fiber, or match fiber to individual tolerance.
Ketogenic and carnivore diets
Is a strict long-term carnivore diet generally a healthy, nutritionally adequate way for humans to eat?
The discussion asks whether long-term eating only animal foods can keep humans healthy and nutritionally replete, rather than needing plants.
Cancer metabolic theories
Can a ketogenic diet reverse or cure cancer?
From late 2025 into 2026, podcast guests dispute whether a ketogenic diet can reverse or cure cancer.
Carbohydrates and fiber
Does consuming meat increase cancer risk?
Shows dispute whether consuming meat increases cancer risk.
Omega-3 and fish consumption
Do omega-3s meaningfully improve cognition or protect the brain?
Guests dispute whether omega-3s meaningfully improve cognition or protect the brain, from February through September.
Weight loss strategies
Is a caloric deficit the most relevant factor for weight loss?
Speakers dispute whether a caloric deficit is the most relevant factor for weight loss.
Sun exposure and sunscreen
Should people wear sunscreen every day?
Podcasts dispute whether people should wear sunscreen every day.
Genetics and disease risk
Are genetics a minor contributor to common chronic diseases and longevity?
Speakers dispute whether genetics are a minor contributor to chronic diseases and longevity, versus a major one.
AI risks and capabilities
Has AI already achieved meaningful recursive self-improvement beyond what human-led model development alone provides?
The dispute is whether current AI already achieves meaningful recursive self-improvement that speeds its own development beyond human-led work.
Should governments now impose a strong pause or significant slowdown on frontier AI development?
Over the past few weeks, podcasts have debated whether to impose a strong pause or major slowdown on frontier AI development through regulation or international agreements.
Will advances in AI and automation lead to large long-term net job losses or mass unemployment, rather than overall job creation?
The debate is whether AI and automation will cause enduring net job losses or instead reshape work while expanding overall employment opportunities.
In the near term, should AI policy and discourse prioritize catastrophic loss-of-control risks over practical applications and near-term issues?
The dispute is whether near‑term AI policy should focus more on catastrophic loss of control or on practical applications and immediate operational problems.
AI alignment and scaling
Can advanced AI systems be made reliably honest and non-deceptive using improved training, oversight, and transparency methods?
People are debating whether advanced AI can be trained, overseen, and monitored so that it reliably avoids deceptive behavior.
Will increasing the scale of current-style AI models keep yielding large capability gains without major slowdown in the near future?
The dispute is whether scaling up current-style AI models with more parameters, data, and compute will keep yielding big capability gains soon or start to stall.
Do current AI architectures allow reliable monitoring and steering of models' thoughts?
Speakers dispute whether current AI architectures allow reliable monitoring and steering of models' thoughts.